|
|
|
|
|
|
Venturepharm Laboratories Limited, a member of Venturepharm Holdings, a listed company on the Hong Kong Stock Market (8225).
VPSAPI’s expertise in organic synthesis, process development and a c, and controlled supply chain, and coupled with a record of over 20 patents application annually , ensures the satisfaction from the most demanding customers of bulk APIs with high quality and competitive price.
Key services include:
· Develop specific-structure compounds preparation techniques
· Customer synthesis of milligram to kilogram quantities
· Large scale synthesis and commercial manufacturing
· Process research, development and optimization
· Analytical services |
|
|
| Adapalene, Mizolastine, levosimendan , Letrozole , Azelidipine, Dopexamine hydrochloride, Zoledronic Acid, Febuxostat, Naratriptan , Riluzole, Voriconazole, Blonanserin , Otilonium Bromide, Cidofivor , Agomelatine, Pramipexole dihydrochloride, Liranaftate, Anagrelide, CAS:132741-81-2, Escitalopram Oxalate |
|
|
| Company : |
Venturepharm Laboratories Limited |
| Email: |
Contact us |
| URL: |
********
********
|
| Phone: |
*********
|
| Fax : |
*********
|
| Country : |
China |
| Address : |
*********
|
|
|
|
|
|
